Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark" or the "Company") has successfully completed a restock shipment of its concentrate products to the Ontario Cannabis Store ("OCS") with The Hank Co. ("Hank") Bubble Hash and The Hazel Co. ("Hazel") Hash Sticks. The OCS is the wholesaler and online retailer for recreational cannabis in the province of Ontario.
Bruce Dawson-Scully, CEO stated, "With Ontario holding the greatest number of stores among the provinces, we are happy to continue fulfillment of our solventless concentrate brands and products to the province of Ontario."
Hank is Embark's flagship brand under its solventless line of concentrates
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7351/82055_79f256fb94558962_002full.jpg
Hank is Embark's flagship concentrate brand under its solventless line. The Hank Bubble Hash is produced from quality whole flower trichome heads only, resulting in a flavourful experience. Produced through ice water extraction, the result is a light and golden hued, dabbable concentrate. Other concentrate products under the Hank brand, like Hank Pressed Hash, will soon be listed on the OCS and supplied to Ontario.
Hazel is Embark's premier brand under its solventless line of concentrates
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7351/82055_79f256fb94558962_003full.jpg
Hazel is Embark's premier concentrate brand under its solventless line. The Hazel Hash Sticks are a unique solventless concentrate for discerning cannabis connoisseurs who wish to expand their "go-to" options for concentrates. The hash sticks come in a pre-roll form, hand-crafted into a 1-gram hollow tube, and contain no paper or filter.
Make sure to follow Embark Health Inc. on LinkedIn, Facebook, and Instagram to keep up with latest news. Follow The Hank Co. on Instagram and Facebook, and The Hazel Co. on Instagram and Facebook.
About Embark Health Inc.
Embark Health Inc. is a leader in solventless cannabis extraction, with a focus on the formulation and production of advanced 2.0 products for the B2B, medical, and adult-use markets. Embark continues to be at the forefront of production of concentrate products including bubble hash, traditional pressed hash, rosin, and dry sift. Building on Embark's strength in innovation and creating industry-leading Cannabis 2.0 products, it recently announced new product offerings through its proprietary ground-breaking Embark Nano technology. The new suite of products coming to market include cannabis-infused beverages, topicals, edibles and water-soluble powders.
Embark-managed brands of next generation 2.0 products include The Hank Co. and The Hazel Co. under its line of solventless products, and, Distilled + Infused and Meridian under its line of beverage and topical products that utilizes the Embark Nano Technology.
It is Embark's mandate to pursue best-in-class production processes resulting in premium quality commercial and consumer extraction products. Embark Health Inc. is dedicated to unleashing the full potential of the cannabis plant through scientific approaches to extraction and the production of quality products to enhance everyday life. For more information, please visit www.embarkhealthinc.com.
Investor Relations Contact:
IR@embarkhealthinc.com
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking information" within the meaning of applicable securities laws including statements regarding the ability to leverage its existing Cannabis 2.0 products for the Canadian market, access to future markets, Embark's ability to increase production and offer new products and services following receipt of applicable licences, the continued business-to-business activities of Embark, and the effects of the aforementioned activities on the operational and financial condition of Embark. Although Embark believes in light of the estimates by management, current conditions and expected future developments and other factors, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them. Accordingly, Embark can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, changes in economic conditions or financial markets; regulatory delays; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. The statements in this press release are made as of the date of this release. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company.
NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/82055
